Business
LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2019 Results
LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its
About this update from Livanova Plc
[{"type":"text","content":" LONDON--(BUSINESS WIRE)--\nLivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth quarter and full-year 2019 results on Wednesday, Feb. 26, 2020 at 1 p.m. London time (8 a.m. Eastern Standard Time). The Company will release its fourth quarter and full-year 2019 results prior to the call.\n\n\nA live webcast of the conference call will be available on the Investor Relations section of the LivaNova website at www.livanova.com. To listen to the conference call by telephone, dial 877-272-0401 (if dialing from within the U.S.) or 706-902-4062 (if dialing from outside the U.S.). The conference ID is 6456945. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the webcast. A replay will be available on the LivaNova website for 90 days following the call.\n\n\nAbout LivaNova\n\n\nLivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 4,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide. LivaNova operates as two businesses: Cardiovascular and Neuromodulation, with operating headquarters in Mirandola (Italy) and Houston (U.S.), respectively.\n\n\nFor more information, please visit www.livanova.com.\n\n\nSafe Harbor Statement\n\n\nThis news release contains forward-looking statements within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical facts but are based on certain assumptions of management and describe LivaNova’s future plans, strategies and expectations. Forward-looking statements can generally be identified by the use of forward-looking terminology, including, but not limited to, \"may,\" “could,” “seek,” “guidance,” “predict,” “potential,” “likely,” \"believe,\" \"will,\" \"expect,\" \"anticipate,\" \"estimate,\" \"plan,\" \"intend,\" \"forecast,\" or variations of...